Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)

China flag China · Delayed Price · Currency is CNY
65.08
-3.68 (-5.35%)
May 12, 2026, 3:00 PM CST
Market Cap5.46B +51.6%
Revenue (ttm)326.02M -6.9%
Net Income-32.78M
EPS-0.39
Shares Out83.87M
PE Ration/a
Forward PEn/a
Dividend6.80 (9.89%)
Ex-Dividend Daten/a
Volume3,275,688
Average Volume2,016,921
Open67.90
Previous Close68.76
Day's Range64.59 - 68.58
52-Week Range43.91 - 94.00
Beta0.78
RSI59.50
Earnings DateApr 23, 2026

About SHA:688399

Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. The company offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. It also provides HPV and cervical cancer testing services, respiratory infection detection solution, solutions for infectious diarrhea, and STI detection solution for reproductive tract infections. Jiangsu Bioperfectus Technologies Co., Ltd. was founde... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 586
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688399
Full Company Profile

Financial Performance

In 2025, SHA:688399's revenue was 339.05 million, a decrease of -3.02% compared to the previous year's 349.61 million. Losses were -41.08 million, 1952.2% more than in 2024.

Financial Statements